Brief: Granules Says FDA Approval For Lisdexamfetamine Dimesylate Capsules
30/01/2025 09:48
Jan 30 (Reuters) - Granules India Ltd GRAN.NS :
* GRANULES - FDA APPROVAL FOR LISDEXAMFETAMINE DIMESYLATE
CAPSULES
Source text: ID:
Further company coverage: GRAN.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake